Ho C - Search Results

1

Real world duration of curative intent breast, colorectal, non-small cell lung, and prostate cancer treatment.

Wong SK, Hamm J, Shokoohi A, McGahan CE, Ho C. Wong SK, et al. Among authors: ho c. BMC Cancer. 2021 Mar 2;21(1):215. doi: 10.1186/s12885-021-07923-4. BMC Cancer. 2021. PMID: 33653306 Free PMC article.

2

Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North America.

Ho C, Murray N, Laskin J, Melosky B, Anderson H, Bebb G. Ho C, et al. Lung Cancer. 2005 Aug;49(2):225-31. doi: 10.1016/j.lungcan.2005.02.011. Lung Cancer. 2005. PMID: 15925429

3

Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysis.

Ho C, Ng K, O'Reilly S, Gill S. Ho C, et al. Clin Colorectal Cancer. 2005 Nov;5(4):279-82. doi: 10.3816/ccc.2005.n.040. Clin Colorectal Cancer. 2005. PMID: 16356306

4

Second-line treatment for advanced-stage non-small-cell lung cancer: current and future options.

Ho C, Davies AM, Lara PN Jr, Gandara DR. Ho C, et al. Clin Lung Cancer. 2006 May;7 Suppl 4:S118-25. doi: 10.3816/clc.2006.s.003. Clin Lung Cancer. 2006. PMID: 16764752 Review.

5

Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients.

Pugh TJ, Bebb G, Barclay L, Sutcliffe M, Fee J, Salski C, O'Connor R, Ho C, Murray N, Melosky B, English J, Vielkind J, Horsman D, Laskin JJ, Marra MA. Pugh TJ, et al. Among authors: ho c. BMC Cancer. 2007 Jul 13;7:128. doi: 10.1186/1471-2407-7-128. BMC Cancer. 2007. PMID: 17626639 Free PMC article.

6

Early clinical trial experience with vaccine therapies in non-small-cell lung cancer.

Ho C, Ochsenbein AF, Gautschi O, Davies AM. Ho C, et al. Clin Lung Cancer. 2008 Feb;9 Suppl 1:S20-7. doi: 10.3816/clc.2008.s.004. Clin Lung Cancer. 2008. PMID: 18540531 Review.

7

EGFR-directed therapies to treat non-small-cell lung cancer.

Ho C, Laskin J. Ho C, et al. Expert Opin Investig Drugs. 2009 Aug;18(8):1133-45. doi: 10.1517/13543780903066772. Expert Opin Investig Drugs. 2009. PMID: 19572809 Review.

8

Primary tumor resection in patients presenting with metastatic colorectal cancer: analysis of a provincial population-based cohort.

Chan TW, Brown C, Ho CC, Gill S. Chan TW, et al. Among authors: ho cc. Am J Clin Oncol. 2010 Feb;33(1):52-5. doi: 10.1097/COC.0b013e31819e902d. Am J Clin Oncol. 2010. PMID: 19704367

9

The development of a standardized software platform to support provincial population-based cancer outcomes units for multiple tumour sites: OaSIS - Outcomes and Surveillance Integration System.

Wu J, Ho C, Laskin J, Gavin D, Mak P, Duncan K, French J, McGahan C, Reid S, Chia S, Cheung H. Wu J, et al. Among authors: ho c. Stud Health Technol Inform. 2013;183:98-103. Stud Health Technol Inform. 2013. PMID: 23388263

10

Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer.

Ho C, Davies AM, Sangha RS, Lau D, Lara P Jr, Chew HK, Beckett L, Mack PC, Riess JW, Gandara DR. Ho C, et al. Invest New Drugs. 2013 Dec;31(6):1587-91. doi: 10.1007/s10637-013-0024-y. Epub 2013 Sep 8. Invest New Drugs. 2013. PMID: 24013936 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,986 results

Search Page

Filters